News

UK Biotech & Life Sciences News

Follow the latest UK life sciences company news, including biotech funding rounds, pharma partnerships, product launches, clinical updates, infrastructure projects and commercial announcements.

More news

Enterprise Therapeutics Granted EMA Orphan Designation for Cystic Fibrosis Drug ETD001

Enterprise Therapeutics has been granted orphan medicinal product designation by the European Medicines Agency's Committee for Orphan Medicinal Products for ETD001, an inhaled ENaC blocker for cystic fibrosis patients not eligible for CFTR modulator therapy. The company reported a positive Phase 2 outcome earlier in 2026 and will continue development.

Pharmanovia Announces European Commission Approval of Sepalna for Ovarian Cancer

Pharmanovia has announced European Commission approval of Sepalna (senaparib) as first-line maintenance monotherapy for adults with advanced high-grade ovarian, fallopian tube or primary peritoneal cancer that responded to platinum-based chemotherapy. The decision is dated 12 November 2026, and Pharmanovia is the regional development and commercialisation partner for IMPACT Therapeutics, which developed senaparib.

Scottish Brain Sciences Enrols First European Participant in Phase III PrevenTRON Study

Scottish Brain Sciences has enrolled the first participant in Europe in PrevenTRON, a global Phase III study sponsored by Roche. The study tests whether an investigational treatment can delay or prevent symptoms of Alzheimer's disease in at-risk people without memory or thinking problems, and the participant joined at the Aberdeen site.